Spriha Biosciences Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 1.94 Cr
as on 12-12-2024
- Company Age 19 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 9.95 Cr
as on 12-12-2024
- Revenue -53.68%
(FY 2020)
- Profit -101.63%
(FY 2020)
- Ebitda 112.04%
(FY 2020)
- Net Worth -0.55%
(FY 2020)
- Total Assets 139.18%
(FY 2020)
About Spriha Biosciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 1.94 Cr.
The company has closed loans amounting to ₹9.95 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Hanumantha Chennupaty and Srinivasa Cherukuri serve as directors at the Company.
- CIN/LLPIN
U01122TG2005PTC047376
- Company No.
047376
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Sep 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Spriha Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hanumantha Chennupaty  | Director | 08-Sep-2005 | Current |
| Srinivasa Cherukuri | Director | 30-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Spriha Biosciences.
Spriha Biosciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 53.68% decrease. The company also saw a substantial fall in profitability, with a 101.63% decrease in profit. The company's net worth dipped by a decrease of 0.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Spriha Biosciences?
In 2020, Spriha Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Univeg Seed Technologies Private LimitedActive 10 years 7 monthsHanumantha Chennupaty and Srinivasa Cherukuri are mutual person
Mahati Seed Sciences Private LimitedActive 5 years 8 monthsHanumantha Chennupaty is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 12 Sep 2009 | ₹7.45 Cr | Satisfied |
State Bank Of India Creation Date: 18 Nov 2006 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Spriha Biosciences?
Spriha Biosciences has a workforce of 1 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Spriha Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spriha Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
